DUBLIN, Ireland, June 18, 2013 (GLOBE NEWSWIRE) -- In accordance with Rule 2.10 of the Irish Takeover Rules, Warner Chilcott plc (Nasdaq:WCRX) (the " Company") confirms that, as of the close of business on June 12, 2013, the Company's issued share capital consisted of 251,123,743 ordinary shares, par value US$0.01 per share (the " Ordinary Shares"). The CUSIP number for the Ordinary Shares is G94368100.
The Company also confirms that, as of the close of business on June 12, 2013, there were outstanding 2,265,383 restricted share units (the " Restricted Share Units") and 6,205,434 options to purchase Ordinary Shares (the " Share Options") granted by the Company. Upon vesting, each Restricted Share Unit entitles the holder to receive one Ordinary Share, and each Share Option entitles the holder to purchase one Ordinary Share at the applicable exercise price.
The CompanyWarner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the branded pharmaceuticals market, primarily in North America. We are a fully integrated Company with internal resources dedicated to the development, manufacture and promotion of our products. WCRX-G. ENQUIRIES
|Warner Chilcott plc|
|Rochelle Fuhrmann Senior Vice President, Finance (973) 442-3281 firstname.lastname@example.org|